ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
ResMed (NYSE: RMD) announced that CEO Mick Farrell will participate in a fireside chat at the Bernstein Strategic Decisions Conference on June 1, 2022, at 1:30 p.m. EDT in New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) announced that CEO Mick Farrell will participate in a fireside chat at the Bernstein Strategic Decisions Conference on June 1, 2022, at 1:30 p.m. EDT in New York City. This event will provide insights into ResMed's strategies in healthcare innovation. A live webcast will be available on the company's investor relations website, with a replay accessible for one year after the event, until June 1, 2023. ResMed continues to be a leader in digital health technologies aimed at improving the quality of life for patients with chronic diseases.
Positive
- Participation in a prominent industry conference enhances visibility.
- CEO's engagement in discussions reflects strong leadership.
Negative
- None.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was -0.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Time) at the New York Hilton Midtown in New York City.
More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 12 hours after the live webcast ends and will be accessible through June 1, 2023.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com | For media Jayme Rubenstein +1 858.836.6798 news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.